Novartis compound to fight Alzheimer’s disease shows potential.
Novartis Compound designed to fight Alzheimer’s disease shows positive signs in the lab. The molecule is restoring the activity of neurons and neural circuits...
Top Employer”2018- Sanofi
Sanofi Recognized by Top Employers Institute for Good Practice in Employee Development.Sanofi has been officially certified today as a 2018 “Top Employer” by the...
Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer
Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the appointment of...
FuturaGene’s exclusive license for RNAi technology in Eucalyptus enhanced by grant of patent in Brazil
FuturaGene, a wholly owned subsidiary of Suzano Pulp and Paper, and Australia’s Commonwealth Scientific and Industrial Research Organisation (CSIRO), are pleased to announce that...
BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab
BeiGene, Ltd. and Boehringer Ingelheim Biopharmaceuticals (China) Ltd. announced that the two companies have entered into a commercial supply agreement for tislelizumab, BeiGene’s investigational...
JSS and iMedrix Announce Formation of Innovation Centre in Connected Cardiac Care
JSS University, one of the premier medical sciences universities in India and iMedrix, a pioneer in mHealth, announced the formation of an Innovation Centre...
ReCor Medical completes patient enrollment in RADIANCE-HTN SOLO hypertension study
ReCor Medical announced randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's study of its Paradise...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...